Decriminalizing Marijuana Use as an Alternative Medical Treatment

Authors

  • Bima Guntara Universitas Islam Bandung
  • Nandang Sambas Universitas Islam Bandung
  • Oksidelfa Yanto Uiversitas Pamulang

DOI:

https://doi.org/10.61194/law.v2i2.160

Keywords:

Decriminalization, Marijuana, Medical Treatment

Abstract

The discourse surrounding the legalization of Class I narcotics, particularly marijuana (Cannabis Sativa), as one of the alternative medical treatments, has been continuously debated for the past few years. Various studies have been advancing with technological progress, prompting some other countries to start legalizing marijuana for medical purposes with certain restrictions. In Indonesia, there is a clear law, namely Law Number 35 of 2009 concerning Narcotics, which imposes restrictions and prohibitions on the use of various narcotics. Violators of these regulations are subject to criminal sanctions. In this legal research, the author will conduct a literature study using a statutory approach, which involves examining all relevant laws and legal regulations related to narcotics and the legality of the policy on the use of Class I narcotics as alternative medical treatments, such as the 1945 Constitution of the Republic of Indonesia (UUD 45), Law Number 35 of 2009 concerning Narcotics, Law Number 17 of 2023 concerning Health, and Law Number 39 of 1999 concerning Human Rights. The research findings indicate that juridically, the Narcotics Law, especially Article 6 paragraph (1) letter a and Article 8 paragraph (1), prohibits the use of Class I narcotics for medical purposes, which is clearly contradictory to Article 28C paragraph (1) of the 1945 Constitution where every person has the right to develop themselves through the fulfillment of their basic needs, the right to education, and to benefit from science and technology, arts, and culture, for the purpose of improving their quality of life and the welfare of humanity. Furthermore, the Health Law does not specifically regulate the use of marijuana for medical purposes, but only addresses general regulations regarding the use of narcotics. It is hoped that the results of this research can become a reference for policy makers to legalize the use of marijuana as an alternative treatment.

References

Jeong, J. H., Jung, J., Kim, H. J., Lee, J. W., Ko, B. S., Son, B. H., Jung, K. H., & Chung, I. Y. (2023). Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: A nationwide cohort study. Annals of Surgical Treatment and Research, 104(2), 71–79. https://doi.org/10.4174/astr.2023.104.2.71

Shimamoto, T., Tateyama, Y., Kobayashi, D., Yamamoto, K., Takahashi, Y., Ueshima, H., Sasaki, K., Nakayama, T., & Iwami, T. (2023). Survival and medical costs of non-small cell lung cancer patients according to the first-line treatment: An observational study using the Kyoto City Integrated Database. Thoracic Cancer, 14(17), 1574–1580. https://doi.org/10.1111/1759-7714.14900

Teeple, A., Zhdanava, M., Pilon, D., Caron-Lapointe, G., Lefebvre, P., & Joshi, K. (2023). Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance. Current Medical Research and Opinion, 39(8), 1167–1174. https://doi.org/10.1080/03007995.2023.2239045

Thakkar-Samtani, M., Heaton, L. J., Kelly, A. L., Taylor, S. D., Vidone, L., & Tranby, E. P. (2023). Periodontal treatment associated with decreased diabetes mellitus–related treatment costs: An analysis of dental and medical claims data. Journal of the American Dental Association, 154(4), 283-292.e1. https://doi.org/10.1016/j.adaj.2022.12.011

Tlali, M., Scheibe, A., Ruffieux, Y., Cornell, M., Wettstein, A. E., Egger, M., Davies, M.-A., Maartens, G., Johnson, L. F., & Haas, A. D. (2022). Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study. International Journal of Drug Policy, 109. https://doi.org/10.1016/j.drugpo.2022.103853

Venetis, C., Choi, S. K. Y., Jorm, L., Zhang, X., Ledger, W., Lui, K., Havard, A., Chapman, M., Norman, R. J., & Chambers, G. M. (2023). Risk for Congenital Anomalies in Children Conceived With Medically Assisted Fertility Treatment. Annals of Internal Medicine, 176(10), 1308–1320. https://doi.org/10.7326/M23-0872

Wyder, M., Bland, R., Herriot, A., & Crompton, D. (2015). The experiences of the legal processes of involuntary treatment orders: Tension between the legal and medical frameworks. International Journal of Law and Psychiatry, 38, 44–50. https://doi.org/10.1016/j.ijlp.2015.01.006

Yoon, B., & Kim, H.-J. (2022). Patterns of dementia treatment in older adults with Parkinson’s disease using nationwide medical claims data. BMC Geriatrics, 22(1). https://doi.org/10.1186/s12877-022-03028-0

Ardinata, Mikho. “Tanggung jawab negara terhadap jaminan kesehatan dalam perspektif hak asasi manusia.” Jurnal Ham 11.2 (2020): 319-332

Brian Maciver, “Cannabis Legalization World Map: UPDATED”, https://www.cannabisbusinesstimes.com/article/cannabis-legalization-world-map/ , diakses pada 30 Januari 2024

Budiarto, M. SH, Ekstradisi dalam Hukum Nasional (Jakarta: Ghalia Indonesia, 2014)

C.S.T Kansil, “Pengantar hukum kesehatan Indonesia”, (Jakarta: Rineka Cipta, 1991)

Dikutip Dari “Undang-Undang Republik Indonesia Nomor 8 Tahun 1976” Tentang Pengesahan Konvensi Tunggal Narkotika 1961 Beserta Protokol Yang Mengubahnya

Gilang Y. (2020). Bersiasat Dengan Ganja. Retrieved from https://www.cnnindonesia.com/laporanmendalam/nasional/20160919/demamganja-di indonesia/index.php

Hartanto. Wenda” Jurnal Legislasi Indonesia Volume 14 Nomor 1 Tahun 2017

Ilham Choirul Anwar, Senyawa Ganja THC dan CBD: Perbedaan, Efek ke Tubuh, Manfaat Medis, https://tirto.id/senyawa-ganja-thc-dan-cbd-perbedaan-efek-ke-tubuh-manfaat-medis-f7M2, diakses 18 September 2021

Ismansyah, Ismansyah, Siska Elvandari, and Syofirman Sofyan. “Rehabilitasi Medik Terhadap Pasien yang Menggunakan Ganja Medis dalam Pengawasan Sebagai Pemenuhan Hak Atas Kesehatan di Indonesia.” UNES Law Review 6.1 (2023): 3390-3402

Mimin Dwi Hartono et al., Standar Norma dan Pengaturan Nomor Tentang Hak Atas Kesehatan, Komnas HAM – Perpustakaan nasional, Jakarta, 2021

Mohammad Fakhri Abdul Malik, Nandang Sambas, Analisis Yuridis Kriminologis Tindak Pidana Peredaran Narkotika yang Dilakukan oleh Anak Dibawah Umur, Bandung Conference Series: Law Studies, Volume 2, No. 1, Tahun 2022, Hal: 87-94. https://doi.org/10.29313/bcsls.v2i1.455

Muhaimin, Metode penelitian hukum, Mataram Universitas Press, Mataram, 2020

Oksidelfa Yanto, Negara Hukum, Kepastian, Keadilan, dan Kemanfaatan Hukum Dalam Sistem Peradilan Pidana Indonesia, Pustaka Reka Cipta, Bandung, 2020

Petzke, Frank, Tölle, Thomas, Fitzcharles, Mary Ann, & Häuser, Winfried. (2022). “Cannabis-based medicines and medical cannabis for chronic neuropathic pain”. CNS Drugs, 36(1), 31–44. https://doi.org/10.1007/s40263-021-00879-

Pijar Anugerah, “Medical marijuana: Santi Warastuti's struggle to find treatment for her child”, https://www.bbc.com/indonesia/indonesia-61956811, diakses tanggal 28 Juni 2022

Putri, G. S. (2020). PBB Putuskan Ganja Masuk Golongan I Narkotika, Bagaimana di Indonesia? Retrieved S. https://www.kompas.com/sains/read/2020/12/04/133531223/pbb putuskan-ganja-masuk-golongan-i-narkotika-bagaimana-di-indonesia?page=all

Putri, D., & Blickman, T. (2016). Ganja di Indonesia Pola Konsumsi, Produksi, dan Kebijakan. Amsterdam: Transnational Institute

Rahman Syamsuddin, Ahmad Taufik, Pemusnahan Barang Bukti Tindak Penyalahgunaan Narkotika di Kejaksaan Negeri Makassar, Jurnal Aldev: Jurnal Ilmu Hukum Fakultas Syariah dan Hukum, Volume 3 Nomor 2, (Agustus, 2021)

Tim. LGN, “Hikayat Pohon Ganja 12.000 tahun menyuburkan peradaban manusia”, (Jakarta: Gramedia Pustaka Utama, 2011)

Undang-Undang Nomor 7 Tahun 1997 tentang Pengesahan United Nations Convention Against Illicit Traffic in Narcotic Drugs And Psychotropic Substance

Widya Citra Andini, Manfaat Ganja dalam Medis Plus Efeknya untuk Kesehatan, https://hellosehat.com/herbal-alternatif/herbal/manfaat-ganja-secara-medis/, diakses 27 Oktober 2021

Wu, Mariah M., Zhang, Xinwen, Asher, Melissa J., & Thayer, Stanley A. (2019). “Druggable targets of the endocannabinoid system: Implications for the treatment of HIVassociated neurocognitive disorder.”, Brain Research, 1724, 146467. https://doi.org/10.1016/j.brainres.2019.146467

Downloads

Published

2024-05-28

Issue

Section

Articles